C4 Therapeutics Inc. (CCCC)
NASDAQ: CCCC
· Real-Time Price · USD
2.86
0.40 (16.26%)
At close: Aug 18, 2025, 3:59 PM
2.80
-2.05%
After-hours: Aug 18, 2025, 07:58 PM EDT
16.26% (1D)
| Bid | 2.8 |
| Market Cap | 203.55M |
| Revenue (ttm) | 27.78M |
| Net Income (ttm) | -111.58M |
| EPS (ttm) | -1.59 |
| PE Ratio (ttm) | -1.8 |
| Forward PE | n/a |
| Analyst | Hold |
| Ask | 2.93 |
| Volume | 3,381,154 |
| Avg. Volume (20D) | 1,484,311 |
| Open | 2.46 |
| Previous Close | 2.46 |
| Day's Range | 2.46 - 3.06 |
| 52-Week Range | 1.08 - 7.22 |
| Beta | 2.98 |
About CCCC
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CCCC
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CCCC stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
C4 Therapeutics Inc. is scheduled to release its earnings on
Oct 30, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
+31.63%
C4 Therapeutics shares are trading higher after th...
Unlock content with
Pro Subscription
11 months ago
+13.79%
C4 Therapeutics shares are trading higher after the company announced it has delivered a second development candidate to Biogen and earned an $8 million milestone payment.
